Evidence map›Paper›PMID 35215065›Full record

ReviewPathogens (Basel, Switzerland)2022

Advances in Microbiome-Derived Solutions and Methodologies Are Founding a New Era in Skin Health and Care.

Audrey Gueniche, Olivier Perin, Amina Bouslimani, Leslie Landemaine, Namita Misra, Sylvie Cupferman, Luc Aguilar, Cécile Clavaud, Tarun Chopra, Ahmad Khodr

Abstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Protective effect of Bifidobacterium animalis CGMCC25262 on HaCaT keratinocytes.International microbiology : the official journal of the Spanish Society for Microbiology · 2024
    Article
  15. Review
  16. Review
  17. Article
  18. TargetingFrontiers in oncology · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Audrey GuenicheL'Oréal Research and Innovation, 93600 Paris, France.
Olivier PerinL'Oréal Research and Innovation, 93600 Paris, France.
Amina BouslimaniL'Oréal Research and Innovation, Clark, NJ 07066, USA.
Leslie LandemaineL'Oréal Research and Innovation, 93600 Paris, France.
Namita MisraL'Oréal Research and Innovation, 93600 Paris, France.ORCID 0000-0002-9892-8127
Sylvie CupfermanL'Oréal Research and Innovation, 93600 Paris, France.ORCID 0000-0001-8351-3108
Luc AguilarL'Oréal Research and Innovation, 93600 Paris, France.
Cécile ClavaudL'Oréal Research and Innovation, 93600 Paris, France.ORCID 0000-0003-2376-3249
Tarun ChopraL'Oréal Research and Innovation, Singapore 048583, Singapore.
Ahmad KhodrL'Oréal Research and Innovation, 93600 Paris, France.ORCID 0000-0003-2065-4338

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The microbiome, as a community of microorganisms and their structural elements, genomes, metabolites/signal molecules, has been shown to play an important role in human health, with significant beneficial applications for gut health. Skin microbiome has emerged as a new field with high potential to develop disruptive solutions to manage skin health and disease. Despite an incomplete toolbox for skin microbiome analyses, much progress has been made towards functional dissection of microbiomes and host-microbiome interactions. A standardized and robust investigation of the skin microbiome is necessary to provide accurate microbial information and set the base for a successful translation of innovations in the dermo-cosmetic field. This review provides an overview of how the landscape of skin microbiome research has evolved from method development (multi-omics/data-based analytical approaches) to the discovery and development of novel microbiome-derived ingredients. Moreover, it provides a summary of the latest findings on interactions between the microbiomes (gut and skin) and skin health/disease. Solutions derived from these two paths are used to develop novel microbiome-based ingredients or solutions acting on skin homeostasis are proposed. The most promising skin and gut-derived microbiome interventional strategies are presented, along with regulatory, safety, industrial, and technical challenges related to a successful translation of these microbiome-based concepts/technologies in the dermo-cosmetic industry.

Indexed as

cosmeticmethodology harmonizationmicrobiomemicrobiome datamicrobiome metabolitespostbioticsskin health

Identifiers

PMID35215065
PMCPMC8879973

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.